Navigation Links
New research may overturn conventional wisdom on drug-resistant tuberculosis

A newly released study suggests that the majority of cases of drug-resistant tuberculosis (TB) among patients undergoing treatment for the disease may be due to new infections, not acquired resistance. If confirmed in future studies the research, in the March 15 issue of The Journal of Infectious Diseases, may drive a major shift in strategy for controlling TB.

A major difficulty in treating patients with pulmonary TB is that the organism can become progressively resistant to standard therapy. This resistance was long thought to be acquired through mutations in the infecting strain when the treatment regimen was inadequate or the patient did not comply with it. More recently, studies of the genetic make-up of Mycobacterium tuberculosis (M. tuberculosis) strains have shown that resistance can also result from re-infection with a new strain that is already drug-resistant, sometimes against multiple drugs.

The authors of the new study, Qian Gao, PhD, and coworkers in Shanghai, China and elsewhere, used molecular genetics and drug susceptibility testing to investigate patients with TB who were treated in Shanghai hospitals during 1999-2004. They focused on 38 patients from whom samples were available before and during treatment. The researchers found that the strains of TB in the samples taken before treatment were genetically different from those taken during treatment in 87 percent (33 out of 38) of patients.

To determine the relative proportion of drug resistance caused by re-infection or mutation, the authors excluded six patients who were initially infected with resistant TB and then became drug-susceptible or resistant to fewer drugs. In the remaining 32 patients, the initial sample was drug-susceptible or resistant to at least one drug and the subsequent sample resistant to one or more drugs. Of these patients, 84 percent (27 patients) had before-and-during samples with different genetic patterns and only 16 percent (5 patients) had id
'"/>

Source:Infectious Diseases Society of America


Page: 1 2 3

Related biology news :

1. Columbia research lifts major hurdle to gene therapy for cancer
2. U of M researcher examines newly emerging deadly disease
3. NYU researchers simulate molecular biological clock
4. First atlas of key brain genes could speed research on cancer, neurological diseases
5. New research questions basic tenet of neuron function
6. Vital step in cellular migration described by UCSD medical researchers
7. ASU researchers finds novel chemistry at work to provide parrots vibrant red colors
8. UCSD researchers maintain stem cells without contaminated animal feeder layers
9. Why do insects stop breathing? To avoid damage from too much oxygen, say researchers
10. New protein discovered by Hebrew University researchers
11. First real-time view of developing neurons reveals surprises, say Stanford researchers

Post Your Comments:
(Date:11/30/2009)...to rise scientists are presented with the complex ... adapt. In a paper published in Insect Conservati...and Dr Miguel Rodriguez assess this challenge. , ... 0.6˚C has already affected the Earth,s biota... evolutionary biologists is to predict how biologi...
(Date:11/30/2009)...in the December 2009 print issue of The FASEB Jou...ol over their fertility that women have had since ...w and where androgenic hormones work in the testis...lity. This opens a promising avenue for the develo...fers hope to those who cannot have children becaus...
(Date:11/26/2009)...ers, red deer have been caught in the hunters, sig... more than decorative. They are lethal weapons tha... from The University of York, UK, has been intrigu...alf a century and has become fascinated by the mec...ng collaboration with Tomas Landete-Castillejos at...
Breaking Biology News(10 mins):How can scientists measure evolutionary responses to climate change? 2Tough yet stiff deer antler is materials scientist's dream 2And the Beat Goes on 55659 1And the Beat Goes on 55659 2Think zinc 3A Molecular sensor could reveal zincs role in diseases 9732 1Think zinc 3A Molecular sensor could reveal zincs role in diseases 9732 2Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 1Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 2Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 3Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 4Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 5Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 6Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 7Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 8Video 3A RE LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non valvular Atrial Fibrillation Patients 55654 9
...est assured that when you,re asleep they are too. ...9 issue of the journal GENETICS ( http://www.gen...souri-Kansas City have shown that the circadian rh...brates are regulated by some of the same "cellular...ficant because the sleep-regulating enzyme analyze...
...ion to the state of the snow on the slopes, there ...looking closely at a South Pole snowfield this Jan...ted by the UK,s National Physical Laboratory (NPL)... as part of the world,s largest inter-comparison b...ow scientists to fully quantify differences betwee...
...xas is up for a new name, based on Southern Method...r has been misidentified. , State Rep. Charles Ge...nge the name of the state dinosaur from Pleurocoe...e massive sauropod ,whose tracks and bones litter ...scientist behind the name change: His master,s lev...
Other Biology News:When it comes to sleep research, fruit flies and people make unlikely bedfellows 2Satellites search out South Pole snowfields 2A case of mistaken dino-identity 2
(Date:11/30/2009)...ov. 30 Dr. Jessica Torrente, Assis...niversity Medical Center in Washington, D.C., demo...c Gamma Imaging (BSGI) in clinical practice as an ...st cancer today at the annual meeting of the Radio...e purpose of the exhibit was to demonstrate how BS...
(Date:11/30/2009)...TTLE, Nov. 30 Cell Thera...ed today that its new class of platinum-based anti...ted a stronger anti-tumor potency and activity com...nds as well as the ability to overcome cisplatin-r...presented in a paper titled "Novel Bis-platinum Co...
(Date:11/29/2009)...ailable in German . , The concept of confin...s. The most famous example is that of quarks which...rof. Bella Lake from Helmholtz-Zentrum Berlin toge...rt for the first time an experimental realization ...a condensed matter system. , The concept of conf...
(Date:11/26/2009)... Ind. - A new generation of ultrasmall transistors...tures called semiconducting nanowires are closer t...IBM, Purdue University and the University of Calif...rned how to create nanowires with layers of differ...ic level, which is a critical requirement for maki...
Breaking Biology Technology:Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Spinons -- confined like quarks 2Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3
... Sangamo,BioSciences, Inc. (Nasdaq: SGMO ) announ... and CEO, will provide an update on the progress o...nd an overview of the,company,s business strategy ...t the 2008 UBS Global Life Sciences Conference in ...live and may be accessed via a link on,the Sangamo...
...6 Nektar,Therapeutics, (Nasdaq: NKTR ) President...scheduled to present at the upcoming UBS 2008 Glob...nd Hyatt New York Hotel on,Tuesday, September 23, ...accessible via a Webcast through a link posted,on ... the Nektar website:, http://www.nektar.com . This...
... http://www.amdl.com ) AMDL, Inc. (Amex: ADL ), a... major operations in China and the US, announced,t...000 private placement,offering of 10% convertible ...Jesup & Lamont Securities Corporation and Dawson J...and CEO of AMDL, Inc., said, "This financing,stren...
Other Biology Technology:Sangamo BioSciences to Present at the UBS Global Life Sciences Conference 2AMDL, Inc. Closes Private Placement of Convertible Notes 2AMDL, Inc. Closes Private Placement of Convertible Notes 3AMDL, Inc. Closes Private Placement of Convertible Notes 4
GENOMIPHI HY KIT 1000 RXN from GE Healthcare, formerly Amersham Biosciences
N-terminal Sequencing from Primm Biotech, Inc.
Japanese medaka Vitellogenin Standard from Cayman Chemical
I-SAGE Ditag PCR Module* from Invitrogen
Biology Products: